Clinical Trial Update: Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating vinorelbine given on a metronomic schedule with bevacizumab as salvage therapy for breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Navelbine (vinorelbine)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED